Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1673 1693
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18252077 | NUTRITIONAL COMPOSITION | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18555582 | FUCOSYLATION AND IMMUNE MODULATION IN CANCER | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18194374 | METHOD FOR TREATING OBESITY AND/OR HYPERTENSION | Final Rejection | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION |
| 18549797 | NOVEL DEALKOXYPHENYLATION REACTION | Non-Final OA | Daiichi Sankyo Company, Limited |
| 18550349 | GLYCOSIDE INHIBITORS OF YEAST | Non-Final OA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS |
| 17593529 | COMPOSITIONS COMPRISING POLAR LIPIDS FOR MAINTAINING OR INCREASING MOBILITY AND VITALITY | Non-Final OA | FONTERRA CO-OPERATIVE GROUP LIMITED |
| 18464082 | ORAL CANINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A CANINE | Non-Final OA | In the Bowl Animal Health, Inc. |
| 18286416 | NUCLEOSIDE ANALOG AND USE THEREOF | Non-Final OA | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES |
| 18550970 | METHOD FOR EXTRACTING NUCLEIC ACID FROM SAMPLE RICH IN POLYPHENOL AND/OR POLYSACCHARIDE | Non-Final OA | INVIRUSTECH |
| 18023325 | METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE WITH CYCLODEXTRINS | Final Rejection | Beren Therapeutics P.B.C. |
| 18043009 | METHODS FOR THE PREVENTION OF CHOLESTEROL CRYSTAL EMBOLIZATION WITH CYCLODEXTRINS | Final Rejection | Beren Therapeutics P.B.C. |
| 18271296 | Use of Inosine in Preparing Drug For Treatment of Corona Virus Disease 2019 | Non-Final OA | PLA ACADEMY OF MILITARY MEDICAL SCIENCES |
| 18270214 | ANTI-OBESITY COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, MORINGA OLEIFERA FERMENTATION PRODUCT PREPARED USING NOVEL MONASCUS PURPUREUS SL1 | Non-Final OA | MBIOMETHERAPEUTICS CO., LTD. |
| 18030947 | METHOD OF SELECTING COMPOSITIONS COMPRISING CROSSLINKED HYALURONIC ACID AND A LOW PROPORTION OF SOLUBLE HYALURONIC ACID OF LOW MOLECULAR WEIGHT | Final Rejection | TEOXANE SA |
| 17794577 | LOCALIZED EXPRESSION OF THERAPEUTIC NUCLEIC ACIDS IN LUNG EPITHELIAL CELLS | Non-Final OA | ENGENE, INC. |
| 18082566 | EXCIPIENTS PROVIDING STABILIZATION AND ENHANCED WATER SOLUBILIZATION AND THEIR USES | Non-Final OA | NanoSynthons LLC |
| 17845248 | ULTRA-LOW MOLECULAR WEIGHT HYALURONIC ACID AND PREPARATION METHOD THEREFOR | Non-Final OA | NANJING LETOP BIOTECHNOLOGY CO., LTD. |
| 17390096 | ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES | Non-Final OA | Boyce Thompson Institute for Plant Research |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy